266 related articles for article (PubMed ID: 18155831)
1. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D
Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831
[TBL] [Abstract][Full Text] [Related]
2. RNAi-mediated silencing of ezrin gene reverses malignant behavior of human gastric cancer cell line SGC-7901.
Wang HJ; Zhu JS; Zhang Q; Guo H; Dai YH; Xiong XP
J Dig Dis; 2009 Nov; 10(4):258-64. PubMed ID: 19906104
[TBL] [Abstract][Full Text] [Related]
3. Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas.
Sarrió D; RodrÃguez-Pinilla SM; Dotor A; Calero F; Hardisson D; Palacios J
Breast Cancer Res Treat; 2006 Jul; 98(1):71-9. PubMed ID: 16538541
[TBL] [Abstract][Full Text] [Related]
4. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells.
Elliott BE; Meens JA; SenGupta SK; Louvard D; Arpin M
Breast Cancer Res; 2005; 7(3):R365-73. PubMed ID: 15987432
[TBL] [Abstract][Full Text] [Related]
5. [Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis].
Li Q; Wu MF; Song AP; Wei JC; Xu G; Lu YP; Ma D
Ai Zheng; 2006 Mar; 25(3):363-6. PubMed ID: 16536996
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
7. Modulation of ezrin and E-cadherin expression by IL-1beta and TGF-beta1 in human trophoblasts.
Karmakar S; Das C
J Reprod Immunol; 2004 Dec; 64(1-2):9-29. PubMed ID: 15596224
[TBL] [Abstract][Full Text] [Related]
8. [The effects of ezrin on the proliferation and the invasiveness of cells of different hepatocellular carcinoma cell lines].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Wu WZ; Zhou K; Liu KD
Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):489-94. PubMed ID: 16867268
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation.
Yuan Z; Wong S; Borrelli A; Chung MA
Biochem Biophys Res Commun; 2007 Oct; 362(3):740-6. PubMed ID: 17764657
[TBL] [Abstract][Full Text] [Related]
10. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
11. [Function of IL-18 in promoting metastasis of lung cancer].
Jiang DF; Liu WL; Lu YL; Qiu ZY; He FC
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):348-52. PubMed ID: 12921563
[TBL] [Abstract][Full Text] [Related]
12. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.
Nam JS; Ino Y; Sakamoto M; Hirohashi S
Clin Cancer Res; 2002 Jul; 8(7):2430-6. PubMed ID: 12114449
[TBL] [Abstract][Full Text] [Related]
13. Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells.
Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR
Eur Surg Res; 2007; 39(4):208-15. PubMed ID: 17396032
[TBL] [Abstract][Full Text] [Related]
14. [The effects of CXCR4 inhibited by RNA interference on metastasis and invasion of breast cancer cell in vitro].
Zhang SC; Qiao L; Gao H
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):473-5. PubMed ID: 17686306
[TBL] [Abstract][Full Text] [Related]
15. Expression of melanocyte-related genes in human breast cancer and its implications.
Montel V; Suzuki M; Galloy C; Mose ES; Tarin D
Differentiation; 2009 Dec; 78(5):283-91. PubMed ID: 19699574
[TBL] [Abstract][Full Text] [Related]
16. ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells.
Ou-Yang M; Liu HR; Zhang Y; Zhu X; Yang Q
Biochimie; 2011 May; 93(5):954-61. PubMed ID: 21352885
[TBL] [Abstract][Full Text] [Related]
17. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
[TBL] [Abstract][Full Text] [Related]
18. Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin.
Sizemore S; Cicek M; Sizemore N; Ng KP; Casey G
Cancer Res; 2007 Jul; 67(13):6183-91. PubMed ID: 17616675
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
[TBL] [Abstract][Full Text] [Related]
20. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
